Welcome to the News Room

European biomedical innovation has left the building (much like Elvis)…

Posted by:

European Court Bans Patents Based on Embryonic Stem Cells.

Oliver Brüstle, director of the Institute of Reconstructive Neurobiology at the University of Bonn, Germany, who had a patent on a method for generating neurons from human embryonic stem cells rejected by the court, called the ruling “the worst possible outcome”, and “a disaster for Europe”.

He and other scientists worry that the ruling will cause European companies and scientists to miss out on commercial applications for embryonic-stem-cell research.


About the Author:

Prof. Meir Pugatch specialises in intellectual property policy, management and exploitation of knowledge assets, technology transfer, market access, pharmacoeconomics and political economy of public health systems. He has extensive experience in economic and statistical modelling and indexing; valuation of assets and design of licensing agreements; and providing strategic advice to international institutions, multinational corporations and SMEs from all sectors of the knowledge economy. Meir’s work is highly international and he has wide-ranging knowledge of North America, Europe, Asia and the Middle East.
  Related Posts
  • No related posts found.